183 related articles for article (PubMed ID: 16361732)
1. Childhood bullous pemphigoid successfully treated with diaminodiphenyl sulfone.
Motegi S; Abe M; Tamura A; Ishii N; Hashimoto T; Ishikawa O
J Dermatol; 2005 Oct; 32(10):809-12. PubMed ID: 16361732
[TBL] [Abstract][Full Text] [Related]
2. A Korean case of anti-p200 pemphigoid.
Cho SB; Kim SC
Yonsei Med J; 2003 Oct; 44(5):931-4. PubMed ID: 14584115
[TBL] [Abstract][Full Text] [Related]
3. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
5. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
6. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid.
Seishima M; Izumi T; Kitajima Y
Eur J Dermatol; 1999; 9(1):39-42. PubMed ID: 9920986
[TBL] [Abstract][Full Text] [Related]
7. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
[TBL] [Abstract][Full Text] [Related]
8. A novel 105-kDa lamina lucida autoantigen: association with bullous pemphigoid.
Cotell SL; Lapiere JC; Chen JD; Iwasaki T; Krusinski PA; Chan LS; Woodley DT
J Invest Dermatol; 1994 Jul; 103(1):78-83. PubMed ID: 8027584
[TBL] [Abstract][Full Text] [Related]
9. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.
Fisler RE; Saeb M; Liang MG; Howard RM; McKee PH
Am J Dermatopathol; 2003 Jun; 25(3):183-9. PubMed ID: 12775979
[TBL] [Abstract][Full Text] [Related]
10. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
11. A vesicular variant of bullous pemphigoid with autoantibodies against unidentified 205- and 150-kDa proteins at the basement membrane zone.
Satoh S; Seishima M; Izumi T; Ito A; Kamiya H; Kitajima Y
Br J Dermatol; 1997 Nov; 137(5):768-73. PubMed ID: 9415239
[TBL] [Abstract][Full Text] [Related]
12. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
13. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
14. Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens.
Trüeb RM; Didierjean L; Fellas A; Elias A; Borradori L
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):338-44. PubMed ID: 10025864
[TBL] [Abstract][Full Text] [Related]
15. Two cases of subepidermal blistering disease with anti-p200 or 180-kD bullous pemphigoid antigen associated with psoriasis.
Yasuda H; Tomita Y; Shibaki A; Hashimoto T
Dermatology; 2004; 209(2):149-55. PubMed ID: 15316172
[TBL] [Abstract][Full Text] [Related]
16. Childhood bullous pemphigoid treated by i.v. immunoglobulin.
Xiao T; Li B; Wang YK; He CD; Chen HD
J Dermatol; 2007 Sep; 34(9):650-3. PubMed ID: 17727369
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
18. [Subepidermal bullous autoimmune dermatosis with linear deposition of IgA amd IgG].
Kersting E; Goebeler M; Hamm H; Rose C; Zillikens D; Bröcker EB
Hautarzt; 2000 May; 51(5):340-4. PubMed ID: 10875072
[TBL] [Abstract][Full Text] [Related]
19. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
[TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
Chimanovitch I; Hamm H; Georgi M; Kroiss M; Stolz W; Apitz C; Bröcker EB; Zillikens D
Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
